RecruitingNot ApplicableNCT06426251

Photobiomodulation Therapy in Patients Receiving Total Knee Arthroplasty

A Randomized Trial of Photobiomodulation Effect in Patients Receiving Total Knee Arthroplasty


Sponsor

National Taiwan University Hospital Hsin-Chu Branch

Enrollment

15 participants

Start Date

May 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Photobiomdoulation is the use of near-infrared light to relieve pain, stimulate healing and reduce inflammation. Swelling and inflammation is a common condition after orthopedics surgeries over extremity and spine. This study aim to evaluate the effect of photobiomodulation over patients after Total Knee Arthroplasty.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Photobiomodulation for people with inflammation, osteoarthritis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPhotobiomodulation

Photobiomodulation therapy will be given daily start on the first day after surgery to post operative day 6


Locations(1)

National Taiwan University Hospital, Hsin-Chu Branch

Hsinchu, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06426251


Related Trials